Catalyst Wire Dossier Catalyst Wire Dossier

Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine

Diphtheria, Tetanus, and Pertussis vaccine, acellular, reduced dose · Institute of Medical Biology, Chinese Academy of Medical Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine [Phase 1, Phase 2]

See pricing